Longitudinal systemic corticosteroid utilization in the UK, 1990-2018

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/31699
• EU PAS number:
  EUPAS30943
• Study ID:
  31699
• Official title and acronym:
  Longitudinal systemic corticosteroid utilization in the UK, 1990-2018
• DARWIN EU® study:
  No
• Study countries:
  United Kingdom
• Study description:
  he study is a historical longitudinal descriptive cohort study, describing the systemic corticosteroid use in patients with a condition (28 initially selected) for which SCS are used between 1990 and 2018. For each of the selected conditions, for each calendar year the number of patients with active condition will be collected, and for these the number of prescriptions for systemic corticosteroids and the total dose taken will be collected. With these data changes in SCS utilisation after the introduction of new SCS-sparing therapies and/or relevant guideline changes will be described.
• Study status:
  Ongoing

Research institution and networks

Institutions

Observational & Pragmatic Research Institute Pte (OPRI)

United Kingdom

Study timelines

Date when funding contract was signed

Actual: 03/06/2019

Study start date

Planned: 02/09/2019

Actual: 02/09/2019

Data analysis start date

Planned: 03/09/2019

Actual: 03/09/2019

Date of interim report, if expected

Planned: 15/12/2019

Date of final study report

Planned: 01/02/2020

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

AstraZeneca

Study protocol

Initial protocol

OPRI_1855_Protocol_190813

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable